Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Eisai synthesizes heterocyclic anticancer compounds

Feb. 11, 1997

Introgen receives milestone payment for gene therapy progress

Feb. 10, 1997

Grant helps fund research into camptothecin analogues

Feb. 10, 1997

Medis El teams with Ramot to develop breast cancer vaccines

Feb. 10, 1997

Antitumor agents from Taiho

Feb. 10, 1997

ADIR prepares antiangiogenic agents

Feb. 10, 1997

RPR's docetaxel now approved in 49 countries

Feb. 7, 1997

Another Isis antisense compound to enter clinic

Feb. 7, 1997

Isis previews antisense anticancer program

Feb. 7, 1997

Follow-up data reported for Amelorad

Feb. 7, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 6, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 6, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.